BR0314911A - Inibidor de infecção pelo vìrus da dengue e anticorpo monoclonal - Google Patents

Inibidor de infecção pelo vìrus da dengue e anticorpo monoclonal

Info

Publication number
BR0314911A
BR0314911A BR0314911-0A BR0314911A BR0314911A BR 0314911 A BR0314911 A BR 0314911A BR 0314911 A BR0314911 A BR 0314911A BR 0314911 A BR0314911 A BR 0314911A
Authority
BR
Brazil
Prior art keywords
virus infection
dengue virus
infection inhibitor
monoclonal antibody
hex
Prior art date
Application number
BR0314911-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Yasuo Suzuki
Iipal Jwa
Original Assignee
Japan Science & Tech Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science & Tech Agency filed Critical Japan Science & Tech Agency
Publication of BR0314911A publication Critical patent/BR0314911A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
BR0314911-0A 2002-10-22 2003-10-22 Inibidor de infecção pelo vìrus da dengue e anticorpo monoclonal BR0314911A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002307232 2002-10-22
PCT/JP2003/013486 WO2004037272A1 (fr) 2002-10-22 2003-10-22 Inhibiteur d'infection a virus de la dengue

Publications (1)

Publication Number Publication Date
BR0314911A true BR0314911A (pt) 2005-09-27

Family

ID=32170933

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314911-0A BR0314911A (pt) 2002-10-22 2003-10-22 Inibidor de infecção pelo vìrus da dengue e anticorpo monoclonal

Country Status (7)

Country Link
US (1) US20060104985A1 (fr)
EP (1) EP1563840A1 (fr)
JP (1) JPWO2004037272A1 (fr)
CN (1) CN1705488A (fr)
BR (1) BR0314911A (fr)
MX (1) MXPA05004379A (fr)
WO (1) WO2004037272A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2349257B1 (fr) 2008-06-17 2013-11-27 Universidade Federal de Minas Gerais-UFMG Utilisation du recepteur du facteur d'activation plaquettaire (paf) dans le traitement des infections causees par flaviviridae

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JPH0725689B2 (ja) * 1986-10-07 1995-03-22 中外製薬株式会社 顆粒球コロニ−刺激因子を含有する徐放性製剤
EP0316764B1 (fr) * 1987-11-20 1994-06-08 Abbott Laboratories Détection de marqueurs associés aux tumeurs dans des fluides biologiques
JPH0687061B2 (ja) * 1988-04-12 1994-11-02 ダイナボット株式会社 糖転移酵素活性の免疫学的測定方法
JPH03115863A (ja) * 1990-09-10 1991-05-16 Dainabotsuto Kk 免疫学的測定法による糖脂質の定量方法
US6197568B1 (en) * 1997-07-29 2001-03-06 The Regents Of The University Of Michigan Method and compositions for isolation, diagnosis and treatment of polyanion-binding microorganisms

Also Published As

Publication number Publication date
WO2004037272A1 (fr) 2004-05-06
JPWO2004037272A1 (ja) 2006-02-23
MXPA05004379A (es) 2005-11-23
CN1705488A (zh) 2005-12-07
EP1563840A1 (fr) 2005-08-17
US20060104985A1 (en) 2006-05-18

Similar Documents

Publication Publication Date Title
BR0307356A (pt) Misturas inseticidas sinergìsticas
PE20040972A1 (es) Intermedio de formulacion aceptablemente no higroscopico que comprende un farmaco higroscopico
BR0307575A (pt) Derivados de sulfonila como inibidores de histona desacetilase
UY29157A1 (es) Composiciones de amitraz
UY29007A1 (es) Derivados de 2-carbamida-4-feniltiazol, su preparacinn, y su aplicacinn en terapcutica
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
RU2009126767A (ru) Производное 1-фенил-1-тио-d-глюцитола
BRPI0207215B8 (pt) Derivados de pirazolopirimidinona tendo ação de inibição de pde7
AR072329A2 (es) Composicion farmaceutica que comprende nateglinida
BRPI0311323B8 (pt) composto inibidor de c-aril glicosídeo sglt2, composição farmacêutica e combinação
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
BRPI0316532B8 (pt) composições farmacêuticas compreendendo uma droga básica ou ácida, um tensoativo, e um ácido ou base solúvel em água fisiologicamente tolerável
AR067030A2 (es) Composiciones farmaceuticas
ES2196527T3 (es) Derivados de 11,15-o-dialquilprostaglandina e, su procedimiento de produccion y medicamentos que incluyen estos como principio activo.
EA200800303A1 (ru) Применение производных и аналогов тиазола при нарушениях, вызванных свободными жирными кислотами
CY1119188T1 (el) Αντιμικροβιακα συντηρητικα για την επιτευξη φαρμακοτεχνικης μορφης πολλαπλης δοσης χρησιμοποιωντας βητα-κυκλοεξτρινες για υγρες μορφες δοσολογιας
BR0212075A (pt) Combinações de substâncias ativas fungicidas
DK1483245T3 (da) 5-substituerede alkylaminopyrazolderivater som pesticider
BR0312768A (pt) Compostos de 5-ariltetrazol, composições do mesmo e usos dos mesmos
BRPI0414386A (pt) composto, métodos para fabricação do mesmo, para tratamento ou prevenção de uma doença, para ativação da função de er em uma célula óssea, para inibição de função de er em uma célula, para inibição da expressão de il-6, para inibição do crescimento de uma célula neoplásica expressando er, para prevenção de espermatogenese, para prevenção de um efeito reprodutivo adverso associados com exposição a uma falta de equilìbrio hormonal natural ou quìmica ambiental, e, composição
BR0312921A (pt) Composição compreendendo inibidor de reductase hmg-coa
BR0203657A (pt) Formulação sólida
BR0307834A (pt) Misturas inseticidas sinergìsticas
BR9915692A (pt) Monohidrato de bromidrato de eletriptano
BR0314911A (pt) Inibidor de infecção pelo vìrus da dengue e anticorpo monoclonal

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE 5A., 6A. E 7A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2069 DE 31/08/2010.